Journal article · 2026 · Open access
Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy
Bulletin of Advanced Drug Delivery and Therapeutics, 12–17 · Published 30 September 2026 · DOI 10.37022/baddt.v1i2.966
In brief
“Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy” is a 2026 journal article by Kalyani R, published in Bulletin of Advanced Drug Delivery and Therapeutics. OpenAlex counts 0 citations as of 21 November 2026. It is open access: the full text is free to read at Bulletin of Advanced Drug Delivery and Therapeutics.
- Citations
- 0
- References
- 14
- Authors
- 1
Abstract
Clinical pharmacogenomics (PGx) is an emerging component of precision medicine that examines how inherited genetic variation influences an individual's response to medicines. Genetic differences affecting drug-metabolizing enzymes, transporters, receptors, immune pathways and therapeutic targets can contribute to interindividual variability in drug efficacy, toxicity and pharmacokinetics. Integration of pharmacogenomic information into clinical practice can therefore support selection of appropriate medicines, individualized dosing and prevention of avoidable adverse drug reactions. Important gene–drug associations include CYP2C19–clopidogrel, CYP2D6–codeine and antidepressants, CYP2C9/VKORC1–warfarin, TPMT/NUDT15–thiopurines, DPYD–fluoropyrimidines and HLA-B*57:01–abacavir. Clinical implementation is supported by evidence-based resources and guidelines developed by organizations such as the Clinical Pharmacogenetics Implementation Consortium (CPIC), the Dutch Pharmacogenetics Working Group (DPWG), PharmGKB and regulatory agencies. However, challenges involving test accessibility, cost, interpretation, healthcare professional education, electronic health record integration, reimbursement, ethical considerations and population diversity continue to limit widespread implementation. Recent developments in pre-emptive panel testing, clinical decision-support systems and standardized genotype-to-phenotype interpretation are facilitating broader integration of PGx into healthcare. This review discusses the principles, clinical applications, implementation strategies, benefits and limitations of clinical pharmacogenomics and highlights its potential role in individualized and safer pharmacotherapy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
R, K. (2026). Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy. Bulletin of Advanced Drug Delivery and Therapeutics, 12–17. https://doi.org/10.37022/baddt.v1i2.966
MLA 9
R, Kalyani. “Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy.” Bulletin of Advanced Drug Delivery and Therapeutics, 2026, pp. 12–17. https://doi.org/10.37022/baddt.v1i2.966.
Chicago
R, Kalyani. 2026. “Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy.” Bulletin of Advanced Drug Delivery and Therapeutics: 12–17. https://doi.org/10.37022/baddt.v1i2.966.
Harvard
R, K. (2026) ‘Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy’, Bulletin of Advanced Drug Delivery and Therapeutics, pp. 12–17. doi:10.37022/baddt.v1i2.966.
IEEE
K. R, “Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy,” Bulletin of Advanced Drug Delivery and Therapeutics, pp. 12–17, 2026, doi: 10.37022/baddt.v1i2.966.
BibTeX
@article{r2026clinical,
title = {{Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy}},
author = {R, Kalyani},
journal = {Bulletin of Advanced Drug Delivery and Therapeutics},
year = {2026},
pages = {12--17},
doi = {10.37022/baddt.v1i2.966},
url = {https://doi.org/10.37022/baddt.v1i2.966}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- clinical pharmacogenomics
- precision medicine
- genetic variation
- drug response variability
- adverse drug reactions
- drug-metabolizing enzymes
- drug transporters
- CYP2D6
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
R, K. (2026). Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy. Bulletin of Advanced Drug Delivery and Therapeutics, 12–17. https://doi.org/10.37022/baddt.v1i2.966
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Bulletin of Advanced Drug Delivery and Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Kalyani R.
What is the DOI of this paper?
10.37022/baddt.v1i2.966, permanently at https://doi.org/10.37022/baddt.v1i2.966. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.